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This study examined the effectiveness of antisense oligonucleotides targeted to intercellular
adhesion molecule-1 (ICAM-1) to inhibit endotoxin-induced upregulation of ICAM-1 and
neutrophil emigration and compared the apparent role of ICAM-1 when examined using
antisense oligonucleotides, anti-ICAM-1 antibodies, and ICAM-1 mutant mice. Antisense
oligonucleotides inhibited upregulation of ICAM-1 mRNA at 4 and 24 h after instillation of
endotoxin in a dose-dependent manner. Neutrophil emigration into the alveolar spaces at
24 h was inhibited by 59%, similar to inhibition using the anti-ICAM-1 antibodies 3E2 (58%)
and YN1/1 (75%). No inhibition was observed in the ICAM-1 mutant compared to wild-type
mice. These data show that antisense oligonucleotides targeted to ICAM-1 inhibit the
endotoxin-induced upregulation of ICAM-1 in the lung and are as effective as anti-ICAM-1
antibodies in preventing neutrophil emigration. The incomplete inhibition by either
antisense oligonucleotides or antibodies suggests that alternative adhesion pathways that
do not require ICAM-1 are important in neutrophil emigration in the lungs. The disparity in
the role of ICAM-1 when evaluated using antisense or antibodies compared to mutant mice
suggests that either these inhibitors are exerting additional effects on endothelial cells other
than blockade of ICAM-1 or mutant mice have upregulated the ICAM-1-independent
pathways to compensate for the long-term loss of ICAM-1.
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This study examined the effectiveness of antisense oligonu-
cleotides targeted to intercellular adhesion molecule-1 (ICAM-1)
to inhibit endotoxin-induced upregulation of ICAM-1 and
neutrophil emigration and compared the apparent role of
ICAM-1 when examined using antisense oligonucleotides,
anti–ICAM-1 antibodies, and ICAM-1 mutant mice. Anti-
sense oligonucleotides inhibited upregulation of ICAM-1
mRNA at 4 and 24 h after instillation of endotoxin in a
dose-dependent manner. Neutrophil emigration into the al-
veolar spaces at 24 h was inhibited by 59%, similar to inhibi-
tion using the anti–ICAM-1 antibodies 3E2 (58%) and YN1/
1 (75%). No inhibition was observed in the ICAM-1 mutant
compared to wild-type mice. These data show that antisense
oligonucleotides targeted to ICAM-1 inhibit the endotoxin-
induced upregulation of ICAM-1 in the lung and are as ef-
fective as anti–ICAM-1 antibodies in preventing neutrophil
emigration. The incomplete inhibition by either antisense
oligonucleotides or antibodies suggests that alternative ad-
hesion pathways that do not require ICAM-1 are important
in neutrophil emigration in the lungs. The disparity in the
role of ICAM-1 when evaluated using antisense or antibod-
ies compared to mutant mice suggests that either these in-
hibitors are exerting additional effects on endothelial cells
other than blockade of ICAM-1 or mutant mice have upreg-
ulated the ICAM-1–independent pathways to compensate

























The presence of endotoxin within the distal airspaces of the
lung induces an inflammatory response that results in the accu-
mulation of neutrophils and the formation of edema within 24 h
(1–5). This response is attributed to the effect of endotoxin on
epithelial cells, alveolar macrophages, and endothelial cells to
induce the production of cytokines. These cytokines subse-
quently induce upregulation of adhesion molecules and emi-
gration of neutrophils acutely and mononuclear cells at later
times.
Previous studies have shown that intraairway instillation of
endotoxin-induced neutrophil emigration into the alveolar
space through adhesion pathways that required CD11/CD18





 mRNA and protein expression on both
capillary endothelial cells and type II alveolar epithelial cells
(4). However, the function of ICAM-1 in mediating CD11/
CD18–dependent emigration has not been clearly defined.
Antisense oligonucleotides that hybridize to a specific
mRNA or pre-mRNA have the potential to inhibit the expres-
sion of the targeted molecule in vivo (6–8). Many studies have
shown that antisense oligonucleotides that hybridized to mes-
sage specific for cytokines, adhesion molecules, or viruses pre-
vented upregulation of expression (9–21). In particular, anti-
sense oligonucleotides targeted to human ICAM-1 mRNA
inhibited its upregulation in human umbilical vein endothelial




(14, 15). While unmodified phosphodiester oligonucleotides
are effective in vitro, the phosphorothioate oligodeoxynucle-
otides, in which sulfur is substituted for one of the nonbridging
oxygen atoms in the phosphate backbone, are less susceptible
to hydrolysis by nucleases and are potentially more effective in
vivo (22, 23). In particular, the antisense oligonucleotide ISIS
3082 has been shown to be effective in delaying acute cardiac
allograft rejection (17, 18), inhibiting colitis (Bennett, C.F., D.
Kornbrust, S. Henry, S. Dutson, W. Hall, and H.I. Jacoby,
manuscript submitted for publication), and preventing carra-
geenin-induced neutrophil emigration into the subcutaneous
space (Bennett, C.F., unpublished data).
The purpose of these studies was to determine if the anti-
sense oligonucleotide ISIS 3082 inhibited the upregulation of





 endotoxin into the distal airways and if inhibiting
the upregulation of ICAM-1 using this technology prevented
the acute inflammatory response. These studies also compared
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EVA, extravascular albumin; G3PDH, glyceraldehyde 3-phosphate
dehydrogenase; ICAM-1, intercellular adhesion molecule-1; VCAM-1,
vascular cell adhesion molecule-1.
 
 




the function of ICAM-1 when inhibited by antisense oligonu-
cleotides, by antibodies that are specific for murine ICAM-1
and block its function, and by genetic elimination of ICAM-1






BALB/c female mice weighing 20–25 g were purchased
from Harlan Sprague Dawley, Inc. (Indianapolis, IN). ICAM-1 mu-




 C57BL/6J) were produced using homologous re-
combination in embryonic stem cells as previously described (24).





ICAM-1 antisense oligonucleotide (3082; ISIS





lated region of the murine ICAM-1 gene (17). The unrelated oligonu-









G ratio was similar to ISIS 3082. The sequences for

















1082 targets the herpes virus UL-13 gene sequence.
These phosphorothioate oligonucleotides were synthesized on a
0.5 mmol scale on a DNA synthesizer (Milligen 8800; Millipore





-cyanoethoxyphosphoramidites as previously described (25). A
crude product of approximately 70% purity was further purified by
column chromatography using a column (HC18-HA; Millipore
Corp.). The purified material was ethanol precipitated, redissolved,
and further desalted by ultrafiltration. The samples were depyroge-
nated by ultrafiltration to yield endotoxin levels reduced to below de-
tectable levels. Purity of the material was assessed by capillary elec-
trophoresis, anion exchange HPLC, and nuclear magnetic resonance.
The oligonucleotides were found to be greater than 92% full-length




Two blocking antimurine ICAM-1 (CD54)
antibodies were used in these studies. Rat antimurine ICAM-1 mono-
clonal antibody YN1/1 was purified as previously described (26, 27).
Rat IgG was used as a control antibody (Sigma Chemical Co., St.
Louis, MO). Azide-free hamster antimurine ICAM-1 monoclonal an-
tibody 3E2 was purchased from PharMingen (San Diego, CA). This
antibody has also been shown to inhibit the function of murine





















Ci/ml and 0.8 mg al-
bumin/ml). Thin layer chromatography using silica gel–impregnated
glass fiber sheets (Gelman Sciences Inc., Ann Arbor, MI) and 80%






Cr) was purchased from DuPont-NEN
(Boston, MA) (concentration 1 mCi/ml) and used to label murine
RBC (29).
 
The effect of ICAM-1 antisense oligonucleotide on E. coli 




BALB/c mice were anesthetized with ketamine hy-
drochloride (80–100 mg/kg i.m.) and acepromazine maleate (8–10
mg/kg i.m.). Anesthetized BALB/c mice received an intravenous in-

















 3 in all other groups). 2 h after administering the oligonu-




l of 2 mg/ml) was instilled into the airways
through the trachea. Control mice received no endotoxin. 4 h after
endotoxin was instilled, the lungs were frozen in liquid nitrogen.
Lung tissue was pulverized and total RNA was extracted using guani-
dinium isothiocynate as described by Chirgwin et al. (30). Total RNA
was separated on agarose/formaldehyde gels and transferred to nylon
membranes. Northern blots were probed for ICAM-1, vascular cell
adhesion molecule-1 (VCAM-1), and glyceraldehyde 3-phosphate
dehydrogenase (G3PDH) mRNA using random primed labeled
cDNA probes. RNA was quantitated using a PhosphorImager (Mo-
lecular Dynamics, Sunnyvale, CA). The increase in ICAM-1 or
VCAM-1 mRNA was normalized for differences in loading using the
G3PDH mRNA and was expressed as a fold increase compared to




Anesthetized BALB/c mice received intrave-
nous injections of ISIS 3082 (100 mg/kg) or saline either 2 h before or













 3 in each group). After 24 h, the lungs were frozen in
liquid nitrogen. Both ICAM-1 and VCAM-1 mRNA were quanti-
tated as described above.
 
The effect of ICAM-1 antisense oligonucleotide on neutrophil 
emigration and edema formation induced by E. coli endotoxin
 
























 10) through the




I-albumin was injected through the tail
vein to measure the extravascular accumulation of albumin in the
lungs (29). The trachea was exposed through a midline incision in the neck


























 5 of either ISIS 3082– or saline-pretreated mice)
was instilled through the intratracheal catheter into the lungs. 4 h af-
ter the intratracheal instillation, a second injection of the same pre-
treatment (either ISIS 3082 (100 mg/kg), ISIS 1082 (100 mg/kg), or





Cr-labeled RBC were injected intravenously and allowed
to circulate for 2 min to measure the pulmonary blood volume, and
the mice received an overdose of halothane. The chest was rapidly
opened, the base of the heart was tied, and a blood sample was taken
from the inferior vena cava. The heart and lungs were removed en
bloc and the lungs were fixed by intratracheal instillation of 4% glutar-





over a scintillation vial to retrieve any spilled fixative. After the heart
and mediastinal structures were removed, radioisotope levels were
measured in the lungs, blood sample, and plasma sample using a
gamma counter interfaced with a PC and software to correct for over-





m sections of lungs were cut and
stained with hematoxylin and eosin to measure neutrophil emigration
as described below.
 
The effect of antimurine ICAM-1 monoclonal antibodies on 
neutrophil emigration and edema formation induced by E. coli 
endotoxin
 
Anesthetized BALB/c mice were pretreated with hamster antimurine



































labeled RBC were given intravenously and neutrophil emigration
and extravascular albumin (EVA) were evaluated as described below.
Anesthetized wild-type mice were pretreated with rat antimurine





















I-albumin. The mice received intratra-




 for 24 h as described above. Neutrophil
emigration and EVA were evaluated as described below.
 
Neutrophil emigration and edema formation induced by E. coli 
endotoxin in ICAM-1 mutant and wild-type mice
 
Anesthetized ICAM-1 mutant and wild-type mice were given an in-




I-albumin to the extravascular accumulation













 5 in each group) was instilled intratracheally as described above.





labeled RBC, and the lungs, blood sample, and plasma sample were
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Quantitation of neutrophil emigration and edema formation in the
lungs. 
 
Neutrophil emigration into the alveolar spaces was quanti-
tated on paraffin-embedded histologic sections using point-counting
techniques to determine the percentage of the distal airspace that was
occupied by neutrophils (31, 32). 500 points were counted in each of
five fields of alveolar space and alveolo-capillary walls on histologic





 alveolo-capillary walls) occupied by intraalveolar
neutrophils was calculated.
Edema formation was quantitated by measuring the EVA. EVA










 intravascular albumin volume











One way analyses of variance were used to compare
the percentages of alveolar tissue occupied by neutrophils and edema
formation. After a significant ANOVA, multiple contrasts were used
with a Bonferroni adjustment to determine which groups were signif-








 0.05 was considered significant. The








The effect of ICAM-1 antisense oligonucleotide on E. coli en-
dotoxin-induced expression of ICAM-1 mRNA. 
 
Endotoxin in-
duced a fivefold increase in ICAM-1 mRNA in the lungs
within 4 h of instillation, but no change in VCAM-1 mRNA
(Figs. 1 and 2). The increase in ICAM-1 mRNA was inhibited
by ISIS 3082 when given at 30 or 100 mg/kg, but not at 1 or 10
mg/kg (Figs. 1 and 2). When animals were studied at 24 h after
instillation of endotoxin, there was still a significant increase in
the ICAM-1 mRNA and no change in VCAM-1 mRNA ex-
pression (Fig. 3). This increase was inhibited when ISIS 3082
was given at a dose of 100 mg/kg both 2 h before and 4 h after
endotoxin, but there was no statistically significant effect when
the compound was given only 2 h before (Fig. 3). ISIS 3082
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The effect of ICAM-1 antisense oligonucleotide on neutro-
phil emigration and edema formation induced by E. coli endo-
toxin. 
 
Histologic sections of lung tissue from mice with endo-
toxin-induced pneumonia given intravenous injections of either
the control antisense oligonucleotide ISIS 1082 or the blocking
oligonucleotide ISIS 3082 are shown in Fig. 4. In control
BALB/c mice given injection of saline instead of antisense oli-





of the distal lung was occupied by emigrated neutrophils 24 h
after instillation of E. coli endotoxin (Fig. 5). In the mice pre-
Figure 1. Northern blot demonstrating inhibition of endotoxin-induced 
upregulation of ICAM-1 mRNA at 4 h after instillation by ISIS 3082 
in a dose-dependent manner.
Figure 2. Inhibition of endotoxin-induced upregulation of ICAM-1 
mRNA at 4 h by antisense oligonucleotide ISIS 3082. Each bar repre-
sents the mean data describing the fold increase in ICAM-1 mRNA 
(filled bars) or VCAM-1 mRNA (slashed bars) normalized for differ-
ences in loading using expression of G3PDH mRNA at 4 h after in-
stillation of the stimulus. ISIS 3082 at doses of 30 or 100 mg/kg inhib-
ited ICAM-1 mRNA expression. *Significantly greater fold induction 
of ICAM-1 mRNA than in mice that received no endotoxin (LPS) or 
from mice given LPS and 30 or 100 mg/kg ISIS 3082 (P , 0.05).
Figure 3. Inhibition of endotoxin-induced upregulation of ICAM-1 
mRNA at 24 h by antisense oligonucleotide ISIS 3082. Each bar rep-
resents the mean data describing the fold increase in ICAM-1 mRNA 
(filled bars) or VCAM-1 mRNA (slashed bars) normalized for differ-
ences in loading using expression of G3PDH mRNA at 24 h after in-
stillation of the stimulus. ISIS 3082 at a dose of 100 mg/kg given 2 h 
before and 2 h after instillation of endotoxin inhibited expression of 
ICAM-1 mRNA, but not when given only 2 h before instillation. 
*Significantly greater fold induction of ICAM-1 mRNA than in mice 
that received no endotoxin (LPS) or from mice given LPS and 100 
mg/kg ISIS 3082 twice (P , 0.05).
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Figure 4. Micrographs of histologic sections of lung tissue from animals given the control antisense oligonucleotide ISIS 1082 (A) and the mu-
rine ICAM-1–targeted oligonucleotide ISIS 3082 (B) and instillation of E. coli endotoxin. Treatment of mice with ISIS 3082 inhibited neutrophil 
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 0.05), indicating that the ICAM-1 antisense
oligonucleotide inhibited neutrophil emigration into the lung
parenchyma by 59%.
The accumulation of edema, as measured by EVA, is
shown in Fig. 6. The lungs of mice that were given ISIS 3082
but did not receive instillation of endotoxin showed no in-
crease in EVA (Fig. 6). Intratracheal instillation of endotoxin
induced a significant increase in edema formation that was not
inhibited by either ISIS 1082 or ISIS 3082 (Fig. 6).
 
The effect of antimurine ICAM-1 monoclonal antibodies on
neutrophil emigration and edema formation induced by E. coli
endotoxin. 
 





0.31% of the alveolar tissue was occupied by
emigrated neutrophils 24 h after instillation of endotoxin (Fig.
5). When mice were pretreated with the hamster anti–ICAM-1





0.18% of the alveolar tissue was occupied by
neutrophils (Fig. 5). This anti–ICAM-1 antibody had no signif-




7 ml) compared to that in mice pre-
treated with hamster IgG (126621 ml, Fig. 7).
In the lungs of rat IgG–pretreated wild-type mice (129/Sv 3
C57BL/6J), 3.4860.61% of the alveolar tissue was occupied by
emigrated neutrophils (Fig. 5). Pretreatment with the rat anti-
murine ICAM-1 antibody YN1/1 prevented neutrophil emi-
gration by 75%, as emigrated neutrophils occupied only
0.8860.07% of the alveolar tissue. The accumulation of EVA
was inhibited by 64% (122619 ml in rat IgG-treated mice,
compared to 5869 ml in wild-type mice, P , 0.05, Fig. 7).
Neutrophil emigration and edema formation induced by E.
coli endotoxin in ICAM-1 mutant and wild-type mice. Emigrated
neutrophils occupied 1.9260.29% of the alveolar tissue in the
lungs of wild-type mice and 1.5460.21% in ICAM-1 mutant
mice 24 h after instillation of endotoxin (P . 0.05, Fig. 5). The
accumulation of EVA was also similar in the lungs of mutant
mice (10669 ml, Fig. 7) compared to wild-type mice (86611 ml).
Discussion
E. coli endotoxin, when instilled into the distal airways of
mice, induced an upregulation of ICAM-1 mRNA by 4 h that
persisted through 24 h, by which time neutrophil emigration
and edema formation were occurring. No change in VCAM-1
mRNA was observed. The antisense oligonucleotide ISIS 3082
prevented this upregulation of ICAM-1 mRNA in a dose-depen-
dent manner at both 4 and 24 h after instillation and had no ef-
fect on the constitutive expression of VCAM-1. The high doses
Figure 5. Neutrophil emigration induced by instillation of E. coli en-
dotoxin for 24 h. The increase in neutrophil emigration induced by 
this stimulus, quantitated morphometrically as the fraction of the al-
veolar tissue occupied by emigrated neutrophils, was inhibited when 
ICAM-1 expression was prevented by intravenous injection of the an-
tisense oligonucleotide ISIS 3082. Neutrophil emigration was also in-
hibited in either BALB/c or wild-type mice when the function of 
ICAM-1 was blocked using anti–ICAM-1 antibodies. However, no 
inhibition of neutrophil emigration was observed when ICAM-1 ex-
pression was eliminated using ICAM-1 mutant mice compared to 
wild-type mice. Significantly less (P , 0.05) than neutrophil emigra-
tion in mice given: *ISIS 1082; **hamster IgG; ***rat IgG.
Figure 6. Extravascular albumin in mice pretreated with ICAM-1 an-
tisense oligonucleotide ISIS 3082. Intratracheal instillation of endo-
toxin induced an increase in EVA compared to mice given instilla-
tions of saline. This increase in EVA was not prevented by treatment 
with either ISIS 1082 or ISIS 3082. ISIS 3082 in mice given instillation 
of saline did not increase EVA. *Significantly less than the EVA in 
mice given either saline or ISIS 3082 but no endotoxin (P , 0.05).
Figure 7. Extravascular albumin in mice given intratracheal instilla-
tion of endotoxin. Only the antibody YN1/1 in wild-type mice par-
tially prevented the formation of edema. No inhibition was observed 
when evaluated using the antisense oligonucleotide, the 3E2 anti-
body, or mutant mice. *Significantly less than the EVA in mice given 
rat IgG (P , 0.05).
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required for complete inhibition of message likely reflect the
low uptake of the oligonucleotide by the lungs observed after
intravenous injection, which was less than 2% of the total
amount injected (35–38). The requirement for a second dose
of ISIS 3082 likely reflects the rapid initial clearance of ISIS
3082 from the plasma (half time of 0.17 h) and its metabolism
within tissues over 24 h (38). However, these doses in the ab-
sence of endotoxin did not injure the lung, as no increase in
permeability was observed when instillation of saline was sub-
stituted for endotoxin. In addition, although the cardiovascular
effects of ISIS 3082 in mice have not been evaluated, similar
phosphorothioate oligonucleotides have been associated only
with sporadic hypotension in monkeys (39–41). These data
suggest that antisense oligonucleotides targeted to ICAM-1
may have important therapeutic uses in the treatment of pa-
tients with ICAM-1–dependent inflammatory responses that
result in lung injury.
Inhibition of ICAM-1 expression by ISIS 3082 significantly
reduced the accumulation of neutrophils within the alveolar
spaces by 59% without an effect on edema formation. This
partial inhibition of neutrophil emigration occurred despite
complete inhibition of the upregulation of ICAM-1 mRNA.
This inhibition was specific to the antisense oligonucleotide
targeted to ICAM-1, as ISIS 1082, a sequence control, had no
effect. However, normal murine lung tissue constitutively ex-
presses detectable levels of ICAM-1 mRNA and protein (4,
42). The antisense oligonucleotide failed to reduce the level of
ICAM-1 mRNA expression below the constitutive level.
These data may suggest that the ICAM-1 expressed normally
on the pulmonary capillaries may be capable of mediating
some neutrophil emigration. Alternatively, endothelial cell ad-
hesion molecules other than ICAM-1 may be mediating the
firm adhesive step during neutrophil emigration, suggesting
that ICAM-1–independent adhesion pathways are operant.
The antisense oligonucleotide was as effective as anti–
ICAM-1 antibodies, in that neutrophil emigration was inhib-
ited by 58% in BALB/c mice given 3E2 and by 75% in wild-
type mice given YN1/1, similar to the 59% inhibition observed
using the antisense oligonucleotide. The slightly greater effect
of YN1/1 may reflect more efficient inhibition that resulted in
partial inhibition of edema formation as well as neutrophil em-
igration. However, the lack of complete inhibition by either
antibody or the antisense oligonucleotide support the hypoth-
esis that alternative adhesion pathways exist.
The rat antimurine ICAM-1 antibody YN1/1 inhibited both
neutrophil emigration and edema formation while the anti-
sense oligonucleotide and the hamster antimurine ICAM-1 an-
tibody 3E2 inhibited only neutrophil emigration. The YN1/1
provided the greatest degree of inhibition in neutrophil emi-
gration, reducing emigration by 75%, compared to 58% by
3E2 and 59% by ISIS 3082. As the formation of edema occurs
through both neutrophil-mediated and neutrophil-indepen-
dent pathways, a large reduction in neutrophil emigration is
likely to be required before a decrease in the total accumula-
tion of edema is observed.
In striking contrast to either the antisense oligonucleotide
or the antibodies, neither neutrophil emigration nor edema
formation were inhibited when the function of ICAM-1 was
evaluated using ICAM-1 mutant mice. These studies suggest
that the manner in which the ICAM-1 is inhibited results in
different apparent functions of this molecule in mediating the
acute inflammatory response. Other studies have also sug-
gested that the apparent function of an adhesion molecule may
vary when evaluated using antibodies compared to mutations.
In particular, ICAM-1 mutant mice showed no defect in neu-
trophil emigration during Pseudomonas aeruginosa–induced
pneumonia while anti–ICAM-1 antibodies inhibited emigra-
tion by 65% (43) (Qin, L., W.M. Quinlan, N.A. Doyle, L.
Graham, J.E. Sligh, F. Takei, A.L. Beaudet, and C.M. Doers-
chuk, manuscript submitted for publication). In addition, co-
bra venom factor–induced acute lung injury was prevented by
anti–ICAM-1 or anti–P-selectin antibodies in wild-type mice,
but was not altered in either ICAM-1 mutant, P-selectin mu-
tant, or ICAM-1/P-selectin double mutant mice (44). In these
two studies, antibodies against an adhesion molecule, either
P-selectin or ICAM-1, had no effect when given to mutant
mice deficient in the same adhesion molecule. One possibility
is that antibodies and antisense oligonucleotides are inducing
more changes in endothelial cells than simply inhibiting the
function or the expression of the targeted adhesion molecule,
although their effects are likely to be through interaction with
the targeted molecule. These additional effects may include al-
terations in signal transduction or changes in the surface of
endothelial cells. Alternatively, the apparent differences may
be due to the time over which the mice are deficient in a mole-
cule. Antibodies and antisense oligonucleotides inhibit the
function of their targets for only a short time before evaluating
the role of the adhesion molecule while mutations prevent the
function of the adhesion molecule after conception. A defect in
adhesion pathways throughout the development and adult life
of mice may allow expression of alternative pathways. The ob-
servation in the present study that complete inhibition of neu-
trophil emigration was never observed using either of two anti-
bodies or the antisense oligonucleotides that induced complete
inhibition of ICAM-1 mRNA upregulation, as well as similar
results by other investigators showing partial inhibition of the
inflammatory response to other stimuli in several species (re-
viewed in reference 45), suggests that ICAM-1–independent
pathways exist in the lungs and are important in neutrophil
emigration. The mutant mice may have upregulated this path-
way to compensate for a deficiency in ICAM-1.
The molecules involved in this alternative pathway have
not been identified. Previous studies examining neutrophil em-
igration in response to E. coli have suggested that the compen-
sating molecule in mutant mice is not P-selectin or E-selectin
(46). Other studies have suggested that alternative adhesion
molecules may be important in acute neutrophil emigration in
the lung and in chronic inflammatory processes in the perito-
neum. For example, Streptococcus pneumoniae induces CD11/
CD18–independent, ICAM-1–independent emigration in the
lung (4, 47). C5a and hydrochloric acid also induce CD11/
CD18–independent adhesion pathways, although the function
of ICAM-1 has not been evaluated (47, 48). Winn and Harlan
have demonstrated that CD11/CD18–independent pathways
of neutrophil emigration occur at later time points in peritoni-
tis induced by stimuli that induced CD11/CD18–dependent
emigration in the initial stages (49). Finally, Pseudomonas
aeruginosa, a stimulus that elicits CD11/CD18–dependent emi-
gration into the alveolar spaces in the initial pneumonia, in-
duces CD11/CD18–independent emigration at the same time
point in recurrent pneumonias at the previously inflamed site
(50). These studies suggest that alternative adhesion pathways
that, to date, are poorly defined, exist in the lungs and other
organs. The mutant mice may provide an opportunity to iden-
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tify either new functions for known molecules or novel adhe-
sion molecules.
In summary, antisense oligonucleotides targeted to ICAM-1,
but not sequence control oligonucleotides, completely pre-
vented endotoxin-induced upregulation of ICAM-1 in the
lung, inhibited neutrophil emigration into the alveolar spaces
to a similar degree as anti–ICAM-1 antibodies, and did not in-
duce lung injury in the absence of endotoxin. These data sug-
gest that antisense oligonucleotides have a potentially impor-
tant therapeutic role in the treatment of ICAM-1–mediated
lung diseases. Despite very effective inhibition of ICAM-1
mRNA expression by ISIS 3082, neutrophil emigration was
only partially prevented by this antisense oligonucleotide and
by anti–ICAM-1 antibodies. No apparent function for ICAM-1
was observed when evaluated using ICAM-1 mutant mice.
These studies suggest that alternative ligands exist and medi-
ate interactions between neutrophils and pulmonary endothe-
lial cells.
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